Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.72 SEK | -12.69% | -1.23% | +121.84% |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Ljung
CEO | Chief Executive Officer | 44 | 05-12-31 |
Mark Beveridge
DFI | Director of Finance/CFO | 46 | 14-12-31 |
Chief Tech/Sci/R&D Officer | 60 | 22-12-31 | |
Sales & Marketing | 62 | 19-01-07 | |
Annica Magnusson
LAW | General Counsel | 61 | 19-01-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Lundmark
BRD | Director/Board Member | 66 | 22-05-15 |
Håkan Wallin
BRD | Director/Board Member | 62 | 23-05-15 |
Nikolaj Sørensen
BRD | Director/Board Member | 52 | 20-12-31 |
Chairman | 64 | 22-05-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,407,452 | 19,288,290 ( 67.90 %) | 445,974 ( 1.570 %) | 67.90 % |
Company contact information
Moberg Pharma AB
Gustavslundsvägen 50 5th Floor
167 51, Bromma
+46 8 52 23 07 00
http://www.mobergderma.seGroup companies
Name | Category and Sector |
---|---|
Moberg Derma Incentives AB
| |
Pharmaceuticals: Major
|
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+121.84% | 99.86M | |
+32.95% | 700B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B | |
-1.81% | 157B |
- Stock Market
- Equities
- MOB Stock
- Company Moberg Pharma AB